Andrew Elnatan

Andrew Elnatan has a strong background in regulatory affairs, with a focus on the biotechnology and pharmaceutical industries. Andrew is currently working as the Vice President of Regulatory Affairs, CMC & Quality at SELLAS Life Sciences Group, Inc. since January 2023. Prior to this, they held the role of Vice President of Regulatory Affairs at SQZ Biotechnologies from November 2020 to January 2023.

Before joining SQZ Biotechnologies, Andrew worked at the International AIDS Vaccine Initiative (IAVI) as the Executive Director of Regulatory Affairs from February 2017 to October 2020. Andrew also held a similar position as the Executive Director of Regulatory Affairs at Celldex Therapeutics from November 2012 to February 2017.

In addition, Andrew has experience as a Director of Regulatory Affairs at Inspiration Biopharmaceuticals, Inc from September 2012 to November 2012, and at Sangart Inc from November 2010 to September 2012.

Andrew started their career at Amgen Inc in 2005, where they held various roles including Director of Regulatory Affairs from October 2007 to November 2010, Senior Manager of Development Operations from July 2006 to September 2007, and Manager of Regulatory Affairs from August 2005 to June 2006. Prior to this, they worked at Amgen Cambridge UK as a Manager of Regulatory Affairs from November 2003 to July 2005.

Andrew Elnatan attended Victorian College of Pharmacy from 1986 to 1988, where they earned a Bachelor's degree (BPharm) in Pharmacy. Andrew then pursued further education at Monash University Pharmacy College from 1990 to 1992, graduating with a Master's degree (MPharm) in Pharmacology.